DXN's investor relations keep shareholders informed about the company's progress and plans
Non-Independent Executive Chairman
Non-Independent Non-Executive Director
Senior Independent Non-Executive Director
Independent Non-Executive Director
Independent Non-Executive Director
Independent Non-Executive Director
Independent Non-Executive Director
to find out more
of the company's
announcements.
For Investor Relations
related queries, please
contact the following:
Declares third interim dividend of 0.8 sen for 3QFY26, totalling RM39.78 million
Cyberjaya, 28 January 2026 – DXN Holdings Bhd. (“DXN” or the “Company”) [德信控股], a leading global manufacturer of nutraceutical products, today announced its unaudited results for the third quarter ended 30 November 2025 (“3QFY26”) and nine months financial results for the financial year ending 28 February 2026 (“9MFY26”) for the Company and its subsidiaries.
Read moreEBITDA margin improves to 28.3%; Board declares second interim dividend
Declares first interim dividend of 0.9 sen, sustains healthy profitability and green infrastructure milestones
• Robust sales : Revenue reaches record-high of RM1.9 billion (FY24 : RM1.8 billion)
• Higher dividend declared: Declares fourth interim dividend of 1.0 sen per share, bringing total full year dividend to 3.7 sen per share, equivalent to a dividend yield of approximately 7% (FY24 : 3.6 sen per share)
• Strong balance sheet: Cash and cash equivalents of RM672.2 million, more than four times total loans and borrowings of RM154.9 million
~ Strengthening presence in fast-growing regions, with Latin America and Asia as key growth drivers ~
~ Declares second interim dividend of 0.8 sen ~
~ Declares first interim dividend of 0.9 sen ~
Health
Food and Beverage
Personal Care
Nutrition
Beauty
Branch
Business
Register